Faeth Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for Faeth Therapeutics, Inc. (FTH) is 865.25M

According to Faeth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 865.25M. This represents a change of 24.65% compared to the average of 3.50M of the last 4 quarters.

Faeth Therapeutics, Inc. (FTH) Historical Enterprise Value (quarterly & annually)

How has FTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Faeth Therapeutics, Inc. over the last ten years is 238.44M. The current 865.25M Enterprise Value has changed 36.19% with respect to the historical average. Over the past ten years (40 quarters), FTH's Enterprise Value was at its highest in in the March 2020 quarter at 578.12M. The Enterprise Value was at its lowest in in the March 2026 quarter at -110465960.96.

Faeth Therapeutics, Inc. (FTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Faeth Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Faeth Therapeutics, Inc. (FTH) Average Enterprise Value

How has FTH Enterprise Value performed in the past?

The current Enterprise Value of Faeth Therapeutics, Inc. (FTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Faeth Therapeutics, Inc. (FTH) Enterprise Value vs. Peers

How is FTH’s Enterprise Value compared to its peers?

Faeth Therapeutics, Inc.’s Enterprise Value is greater than Imunon, Inc. (6.91M), greater than Bolt Biotherapeutics, Inc. (15.16M), greater than Evogene Ltd. (-2819920.09), greater than Cocrystal Pharma, Inc. (15.17M), greater than Dogwood Therapeutics, Inc. (48.86M), greater than Marker Therapeutics, Inc. (8.51M), greater than Cellectar Biosciences, Inc. (-12966810.00), greater than AEON Biopharma, Inc. (10.03M), greater than Cingulate Inc. (47.86M), greater than Traws Pharma, Inc. (4.72M),

Build a custom stock screener for Faeth Therapeutics, Inc. (FTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Faeth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Faeth Therapeutics, Inc. (FTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Faeth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.